Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Abatacept on Apoptosis in Rheumatoid Arthritis
NCT01717846Phase 4Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), sponsored by University of California, Los Angeles. Planned start Dec 2012; status: withdrawn.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01717846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717846.